simple complexity
We unlock the power of neuroscience to ease suffering and enhance human potential. We’re on a mission to transform the way the world treats neurological problems with effective, accessible and non-pharmaceutical solutions that harness the latest in science, technology, engineering and big data.
DESIGN
TECHNOLOGY
POTENTIAL
SOLUTIONS
AXON
Our proprietary Axon system employs electroencephalography (EEG) neurofeedback and combines miniaturised technology, Cloud-based AI and consumer-friendly apps to enable patients to self-treat pain and other neurological conditions at home or in a professional setting. Axon works by monitoring brain activity and then helping the patient retrain their brain to interpret nerve signals in a different way.
Research
Exsurgo is rapidly expanding the global database of quality clinical trials and studies to confirm the effectiveness of its technologies for a range of neurologically-related conditions, prior to commercial rollout.
RECENT NEWS
Clinical trials in a pandemic: why the show must go on
In medicine, triage is a term used to explain how treatment is
That’s So Chronic: Spotlight on Exsurgo
Exsurgo co-founder and CEO Richard Little made a guest appearance on That’s
Exsurgo’s Mindpower Newsletter – July 2022
Hi all, It’s hard to believe it’s been over a year since
Exsurgo’s Mindpower Newsletter – May 2022
Hi all, Last month, we had the immense pleasure of speaking with
Chronic neuropathic pain after surgery is a significant clinical problem (Borsook et al 2013). People with this pain condition may experience shooting, burning pain, numbness or pins and needles, or hypersensitivity to pain. The pain may be constant or may occur intermittently. Unlike most other types of pain, neuropathic pain does not usually get better with common painkillers, such as paracetamol and ibuprofen. Other medicines commonly used include anti-depressants and anti-convulsant.
Two patients with chronic neuropathic pain following back operations successfully used the Axon intervention to reduce pain and increasing mobility.
